LOTUSEYE Charts, Analysis and Tips

home > pharma-and-healthcare > hospitals-and-medical-services > lotuseye

Technical Analysis

Technical Strength: 6 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 61.3. According to RSI analysis, lotuseye just got above it's resistance level and showing good signal. 9.0 LOTUSEYE RSI Chart
MACD (?) MACD: 0.179 and Signal Line: -0.1. According to MACD analysis, lotuseye is technically strong. 8.0 LOTUSEYE MACD Chart
Simple Moving Average (?) According to simple moving average analysis, lotuseye is facing resistance from it's 200-day simple moving average at 31.68575 and support level is at 30.2. 2.0 LOTUSEYE Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 50-day exponential moving average which is a positive signal. According to exponential moving average analysis, lotuseye is in a uptrend. Support level is at 30.5. 9.0 LOTUSEYE Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.947. According to bollinger bands, lotuseye is technically strong. 7.0 LOTUSEYE Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 30.8041 and 29.925. And resistance is at 33.65. 2.0 LOTUSEYE Fibonacci Retracement Chart
Average True Range (?) ATR: 1.63 NA LOTUSEYE Average True Range Chart
Average Directional Index (?) ADX is 15 which means LOTUSEYE is in a trading range and there is no trend. NA LOTUSEYE Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 20, 2018
Open Price 28.75
High Price 32.5
Low Price 28.75
Close Price 31.55
Absolute Change 1.15
Percentage Change 3.78%
Weekly Change 4.47%
Monthly Change 8.05%
Yearly Change 61.4%
52-week high 42.85
52-week low 17.25
Corporate Actions
ExDate Purpose
August 02, 2017 AGM/DIV-RE 0.50 PER SHARE
August 23, 2016 ANNUAL GENERAL MEETING
September 16, 2014 Annual General Meeting
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.757
Confidence in Beta3.22%
Market Capital Rs. 65.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 0.15
TTM Price-to-Earnings (P/E) Ratio 210
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 April 2018: Deliverable Quantity:1.14e+04 NA LOTUSEYE Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 April 2018: Daily Volatility:0.3917 NA LOTUSEYE Annualized Daily Volatility (Spot Price) Chart

Announcements

April 10, 2018 KaDisc. under Reg.30 of SEBI (SAST) Reg.2011aliannagounder Sundaramoorthy, Sangeetha Sundaramoorthy, Dr. Kavetha Sundaramoorthy has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
February 14, 2018 LoOutcome of Board Meetingotus Eye Hospital and Institute Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2018.
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 02, 2018 February 12, 2018 ToResultso inter-alia consider and approve the Un-audited Financial Results for the quarter ended December 31, 2017.
November 03, 2017 November 14, 2017 ToResultso inter-alia consider and approve the Un-audited Financial Results for the quarter ended September 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 25.62 Rs. 27.18 Rs. 29.37 Rs. 30.93 Rs. 33.12 Rs. 34.68 Rs. 36.87